Skip to main content
Clinical Trials/NCT04676191
NCT04676191CompletedNot Applicable

Single- Center Performance Assessment of a Contactless Sensor for Vital Physiological Parameters Measurement at Rest and Detection of Diagnostic Indices in Sleep Compared to Cardiorespiratory Polygraphy

Sleepiz AG1 site in 1 country64 target enrollmentStarted: September 10, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Sleepiz AG
Enrollment
64
Locations
1
Primary Endpoint
Respiration rate measurement accuracy agreement

Study Overview

Brief Summary

The primary aim of this study is to validate the performance of Sleepiz One+ for the measurement of vital physiological parameters in adult population, against a laboratory-based polysomnography. Additionally, the investigators will evaluate Sleepiz One+ ability to identify patients with a high risk of suffering from a sleep-related breathing disorder based on apnea-hypopnea index estimation. Participants will undergo measurement with Sleepiz One+ and a polysomnography device while resting in bed for 20 min as well as during sleep for the duration of the following night.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age >18years
  • •Ability and consent to undergo electrophysiological routine assessment
  • •Informed Consent as documented by signature
  • •Patients diagnosed or suspected to suffer from sleep apnea or any other sleep related disorder or patients suffering from chronic cardiac, respiratory or neuromuscular disorders
  • •Ambulatory or stationary patients of Klinik Lengg

Exclusion Criteria

  • •Previous enrolment into the current study,
  • •Enrolment of the investigator, his/her family members, employees and other dependent persons
  • •Cardiac pacemaker or another implanted electrical device
  • •Women who are pregnant
  • •Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant

Arms & Interventions

Patients with sleep disorders, cardiorespiratory or neuromuscular disorders

Experimental

Intervention: Sleepiz One+ (Device)

Patients with sleep disorders, cardiorespiratory or neuromuscular disorders

Experimental

Intervention: Polysomnography (Device)

Outcomes

Primary Outcomes

Respiration rate measurement accuracy agreement

Time Frame: 60 seconds

Secondary Outcomes

  • Binary classification of sleep apnea severity based on the AHI > 15 of Sleepiz One+ compared to results of Domino software and data manually scored by sleep technician(1 Night)
  • Average respiration rate agreement between Sleepiz One+ and nasal cannula(1 Night)
  • Sleep/wake classification agreement between Sleepiz One+ compared to polysomnography (PSG) data manually scored by sleep technician(60 seconds)
  • Average respiration rate agreement between Sleepiz One+ and thoracic respiratory effort belt(1 Night)
  • Instantaneous respiration rate agreement between Sleepiz One+ and nasal cannula(60 seconds)

Investigators

Sponsor
Sleepiz AG
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials